Cabot Small-Cap Confidential Weekly Update
The big news that affected the market this week was, of course, the dreaded yield curve inversion. This happens when the 10-year Treasury yield goes below the 2-year yield.
Read More
MedTech stocks
Read More
MedTech stocks Archives
Why You Shouldn’t Judge Small-Cap Stocks By the Russell 2000
The best small-cap stocks don't necessarily reside - or stay - in their signature index, the Russell 2000. Here's a better way to find them.
Read More
Cabot Small-Cap Confidential Weekly Update
The market has been up, down and all over the place lately. So have our stocks. Oddly enough, from last Thursday’s close through yesterday’s close our portfolio is relatively unchanged—down just 2% using a simple average of each stock’s weekly return.
Read More
Cabot Small Cap Confidential 243
THE BIG IDEA
Back in the late 1800s if you called a company for information you were routed through a telephone exchange and were able to speak with a person that could help.
The last switchboard operator for a hand-crank phone, Susan Glines, walked away her...
Read More
Cabot Small-Cap Confidential Weekly Update
Our portfolio is outperforming the index by roughly 100%, on average. But we’re not the only ones. Many targeted mutual funds are also demolishing the Russell 2000 Small Cap Index.
Read More
Cabot Small-Cap Confidential Weekly Update
This week marks the beginning of the second-quarter earnings season. I don't foresee any major changes in the trends in any of our companies, but stock price reactions and trends don't always line up in the short term.
Read More
Cabot Small-Cap Confidential Weekly Update
This week’s market recap is a familiar story—the major big-cap market indices are doing great! But the small cap index is still wallowing in the mud.
Read More
Cabot Small Cap Confidential 242
THE BIG IDEA
A few years back the Institute of Medicine (IOM) published a report with an astounding conclusion:
Most people will experience at least one diagnostic error in their lifetime, sometimes with devastating consequences.
That’s not cool.
Diagnostic accuracy of some conditions is staggeringly bad. For the...
Read More
Cabot Small-Cap Confidential Weekly Update
Not surprisingly, this week wasn’t a great one for our portfolio. I had a feeling the party was winding down last week, when we had an average gain of 105% going and had just seen our stocks pop an average of 6% over days...
Read More
Five Bits of Investment Jargon that are Actually Helpful
Investment jargon can be annoying and unnecessary. But if you're a small-cap investor, these five phrases are ones you'll want to know.
Read More
Cabot Small-Cap Confidential Weekly Update
This was another one of those weeks where you look at what the S&P 500 did—up 1.5% to a 52-week high—and you look at what the S&P 600 Small Cap Index did—up 1% to 945 and back above its 50-day line, but well its...
Read More
Cabot Small-Cap Confidential Weekly Update
With the market having come back strong since its swift retreat in early June the immediate threat of a larger correction has diminished. The S&P 500 index is back above its 50-day line and within a couple percentage points of its all-time high.
Read More
Cabot Small Cap Confidential 241
THE BIG IDEA
On a whim, I recently reviewed our car insurance.
Something didn’t feel right, so I went online and got a quote from another provider. It turns out they could cover our two cars with essentially the same coverage – for half the was...
Read More
Cabot Small-Cap Confidential Weekly Update
Altogether it felt like a calm week. Considering the worsening performance of the S&P 600 Small Cap Index, which broke below its comfort zone, and the S&P 500, now 6% off its high, our portfolio’s resiliency continues to stand out.
Read More
Cabot Small-Cap Confidential Weekly Update
Looking at the broad market we see that the S&P 500 is just 4% off its recent high, has thus far held above support around 2,800 and remains above its long-term (200-day) moving average line. The Nasdaq dipped to its May 13 low 7,627,...
Read More
Cabot Small-Cap Confidential Weekly Update
This is a great time to be invested in these stocks, clearly. And I hope the trend continues. But I do think we have a missing ingredient before we can feel super confident that these gains will stick. And that ingredient is more from...
Read More
Cabot Small-Cap Confidential Weekly Update
Everybody’s focus is on the high-stakes chess game the U.S. and China are playing with respect to trade, and the upcoming Uber IPO. But behind the scenes there’s a nice little rally going on in a certain group of small-cap stocks!
Read More
Cabot Small Cap Confidential 240
THE BIG IDEA
One of the big challenges for organizations in the fast-moving digital age is to understand what’s going on in their businesses right now.
Look at Facebook (FB). For a company that specializes in harvesting detailed user data and selling targeted ads you’d they...
Read More
Cabot Small-Cap Confidential Weekly Update
It’s earnings season so most investors are focused on individual stocks. And with the S&P 500 and Nasdaq hitting new all-time highs this week, the big picture is looking pretty good too!
Read More
Cabot Small-Cap Confidential Weekly Update
Prepare yourself for more ups and downs in our medtech & biotech stocks if this debate heats up. I’m not planning to step out of the space since I think this will pass and we can still do quite well with these types stocks.
...
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up